Although debate continues regarding the pro- or anti-neoplastic role of LCN2 in a variety of cancers, our findings suggested that LCN2 may be a promising anti-proliferative and anti-metastatic target for treating GBM in the future. Here, LCN2 is linked to glioblastoma.